UniProt ID | ZN830_HUMAN | |
---|---|---|
UniProt AC | Q96NB3 | |
Protein Name | Zinc finger protein 830 {ECO:0000312|HGNC:HGNC:28291} | |
Gene Name | ZNF830 {ECO:0000312|HGNC:HGNC:28291} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 372 | |
Subcellular Localization | Nucleus . Chromosome . Nucleus speckle . Excluded from nucleolus. | |
Protein Description | May play a role in pre-mRNA splicing as component of the spliceosome. [PubMed: 25599396 Acts as an important regulator of the cell cycle that participates in the maintenance of genome integrity. During cell cycle progression in embryonic fibroblast, prevents replication fork collapse, double-strand break formation and cell cycle checkpoint activation. Controls mitotic cell cycle progression and cell survival in rapidly proliferating intestinal epithelium and embryonic stem cells. During the embryo preimplantation, controls different aspects of M phase. During early oocyte growth, plays a role in oocyte survival by preventing chromosomal breaks formation, activation of TP63 and reduction of transcription (By similarity] | |
Protein Sequence | MASSASARTPAGKRVINQEELRRLMKEKQRLSTSRKRIESPFAKYNRLGQLSCALCNTPVKSELLWQTHVLGKQHREKVAELKGAKEASQGSSASSAPHSVKRKAPDADDQDVKRAKATLVPQVQPSTSAWTTNFDKIGKEFIRATPSKPSGLSLLPDYEDEEEEEEEEEGDGERKRGDASKPLSDAQGKEHSVSSSREVTSSVLPNDFFSTNPPKAPIIPHSGSIEKAEIHEKVVERRENTAEALPEGFFDDPEVDARVRKVDAPKDQMDKEWDEFQKAMRQVNTISEAIVAEEDEEGRLDRQIGEIDEQIECYRRVEKLRNRQDEIKNKLKEILTIKELQKKEEENADSDDEGELQDLLSQDWRVKGALL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASSASART ------CCCCCCCCC | 16.52 | 19413330 | |
3 | Phosphorylation | -----MASSASARTP -----CCCCCCCCCC | 25.74 | 28122231 | |
4 | Phosphorylation | ----MASSASARTPA ----CCCCCCCCCCC | 19.39 | 28122231 | |
6 | Phosphorylation | --MASSASARTPAGK --CCCCCCCCCCCCC | 21.89 | 29414761 | |
9 | Phosphorylation | ASSASARTPAGKRVI CCCCCCCCCCCCCCC | 19.73 | 28450419 | |
40 | Phosphorylation | TSRKRIESPFAKYNR HHHHHCCCHHHHCCH | 23.97 | 25159151 | |
58 | Phosphorylation | LSCALCNTPVKSELL HHHHCCCCCCCHHHH | 28.58 | 21815630 | |
89 | Phosphorylation | LKGAKEASQGSSASS HHCHHHHHCCCCCCC | 35.84 | 17525332 | |
93 | Phosphorylation | KEASQGSSASSAPHS HHHHCCCCCCCCCCC | 38.71 | - | |
100 | Phosphorylation | SASSAPHSVKRKAPD CCCCCCCCCCCCCCC | 28.42 | 25159151 | |
114 | Ubiquitination | DADDQDVKRAKATLV CCCHHHHHHHHHEEC | 55.73 | 24816145 | |
119 | Phosphorylation | DVKRAKATLVPQVQP HHHHHHHEECCCCCC | 27.81 | - | |
129 | O-linked_Glycosylation | PQVQPSTSAWTTNFD CCCCCCCCCCCCCHH | 26.58 | 28510447 | |
137 | Acetylation | AWTTNFDKIGKEFIR CCCCCHHHHHHHHHH | 49.58 | 26051181 | |
146 | Phosphorylation | GKEFIRATPSKPSGL HHHHHHCCCCCCCCC | 20.46 | 25159151 | |
148 | Phosphorylation | EFIRATPSKPSGLSL HHHHCCCCCCCCCCC | 53.49 | 18669648 | |
149 | Acetylation | FIRATPSKPSGLSLL HHHCCCCCCCCCCCC | 44.39 | 26051181 | |
159 | Phosphorylation | GLSLLPDYEDEEEEE CCCCCCCCCCHHHHH | 24.28 | 28796482 | |
181 | Phosphorylation | ERKRGDASKPLSDAQ CCCCCCCCCCCCHHC | 39.28 | 24719451 | |
190 | Acetylation | PLSDAQGKEHSVSSS CCCHHCCCCCCCCCC | 39.93 | 26051181 | |
196 | Phosphorylation | GKEHSVSSSREVTSS CCCCCCCCCCCCCCC | 31.12 | - | |
197 | Phosphorylation | KEHSVSSSREVTSSV CCCCCCCCCCCCCCC | 25.59 | 28985074 | |
201 | Phosphorylation | VSSSREVTSSVLPND CCCCCCCCCCCCCCC | 15.55 | 28985074 | |
223 | Phosphorylation | KAPIIPHSGSIEKAE CCCCCCCCCCCCHHH | 28.96 | 30266825 | |
225 | Phosphorylation | PIIPHSGSIEKAEIH CCCCCCCCCCHHHHH | 30.50 | 30266825 | |
234 | Acetylation | EKAEIHEKVVERREN CHHHHHHHHHHHHHH | 37.10 | 26051181 | |
267 | Acetylation | VRKVDAPKDQMDKEW HEECCCCHHHHHHHH | 63.41 | 7926777 | |
351 | Phosphorylation | KEEENADSDDEGELQ HHHHCCCCCCHHHHH | 44.55 | 22167270 | |
362 | Phosphorylation | GELQDLLSQDWRVKG HHHHHHHHCCCCHHC | 33.13 | 17525332 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN830_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN830_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN830_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SF3B2_HUMAN | SF3B2 | physical | 22365833 | |
ILF3_HUMAN | ILF3 | physical | 22365833 | |
PRP8_HUMAN | PRPF8 | physical | 22365833 | |
SNW1_HUMAN | SNW1 | physical | 22365833 | |
AQR_HUMAN | AQR | physical | 22365833 | |
RED_HUMAN | IK | physical | 22365833 | |
PPIL2_HUMAN | PPIL2 | physical | 22365833 | |
F10C1_HUMAN | FRA10AC1 | physical | 22365833 | |
THOC5_HUMAN | THOC5 | physical | 22365833 | |
PCBP1_HUMAN | PCBP1 | physical | 22365833 | |
AQR_HUMAN | AQR | physical | 26627737 | |
SYF1_HUMAN | XAB2 | physical | 26627737 | |
ISY1_HUMAN | ISY1 | physical | 26627737 | |
PPIE_HUMAN | PPIE | physical | 26627737 | |
PPIL2_HUMAN | PPIL2 | physical | 26627737 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89; SER-351 AND SER-362,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND MASSSPECTROMETRY. |